Summary of Purpose
To compare the safety and efficacy of tissue plasminogen activator (TPA) administered in controlled clinical trials to that of TPA prescribed in routine clinical practice.Read More →
The following dates are available for this trial. Trial information last updated on 9 September 2009.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Boehringer Ingelheim GmbH
Non-controlled, observational study comparing outcomes of non-study patients to those participating in a controlled clinical trial.